UK Patent Case Lowers Bar on Utility (Industrial Application) November 2, 2011Patent, Patent Cases 2011, Pharmaobviousness, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Accessing Brand-Generic Settlement Data January 21, 2011Articles and Publications, Patent, Pharma, SettlementpaidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
In re Glatt Air Techniques, Inc.: Single Embodiment Commercial Success January 6, 2011CAFC, Obviousness, Patent, Pharma, Rantanen, Reexaminationobviousness, paidJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Prometheus Laboratories v. Mayo: The Broad Scope of Statutory Subject Matter December 22, 2010CAFC, Patent, Patent Cases 2010, Patentable Subject Matter, Pharma, RantanenpaidJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Cancer Research Technology v. Barr Laboratories: Prosecution Laches and Inequitable Conduct November 9, 2010Inequitable Conduct, Infringement, Ownership, Patent, Patent Cases 2010, Patent Prosecution, PharmaAffirmed Without Opinion, Federal Circuit En Banc, First to Invent, Inequitable Conduct, paidJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
AstraZeneca v Apotex: Affirmance of a Preliminary Injunction November 4, 2010Anticipation, Injunctions, Patent, Patent Cases 2010, Pharma, Prior Art, Rantanenanticipation, Claim Construction, Enablement, obviousness, paidJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Teva v. Eisai: Standing for subsequent Paragraph IV filers October 6, 2010Declaratory Judgment, Patent, Patent Cases 2010, Pharma, StandingpaidJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Sun Pharmaceuticals v. Eli Lilly: obviousness-type double patenting in the pharmaceutical context August 2, 2010Claim Construction, Obviousness, Patent, Patent Cases 2010, Pharma, RantanenClaim Construction, double patenting, obviousness, paidJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Federal Circuit Review of Patent Term Extensions July 22, 2010Patent, Patent Cases 2010, Patent Term Extension, Pharma, RantanenAIA Trials, paid, PGRJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Federal Circuit Orders Another Case Transferred Out of Texas December 2, 2009Patent, Patent Cases 2009, Pharmaanticipation, paid, VenueDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Irreparable Harm of Generic Competition: Federal Circuit Affirms Finding that Generic Entry Does not Cause Irreparable Harm May 14, 2009Dissent, Injunctions, Obviousness, Patent, Patent Cases 2009, PharmaAffirmed Without Opinion, obviousness, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Federal Circuit Affirms District Court’s Extension of 30-Month FDA Stay February 24, 2009Patent, Patent Cases 2009, Pharma, ProcedurepaidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Patently-O Bits and Bytes No. 85 January 5, 2009Bits and Bytes, Pharmapaid, USPTO DirectorDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Patently-O Bits and Bytes No. 85 January 5, 2009Bits and Bytes, Patent, Pharmapaid, USPTO DirectorDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Prior Art Must Enable a Skilled Artisan to Make the Invention without Undue Experimentation October 6, 2008Enablement, Patent, Patent Cases 2008, PharmaAffirmed Without Opinion, anticipation, Enablement, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Appellate Court Affirms that Generic Omeprazole does not Infringe Prilosec Patent June 10, 2008Infringement, Patent, Patent Cases 2008, PharmapaidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
KSR Extended to Obviate Component Purified from Known Mixture September 11, 2007Chemical, Obviousness, Patent, Patent Cases 2007, Pharmaobviousness, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Zyprexa Patent Upheld on Appeal January 1, 2007Anticipation, CAFC, Chemical, Motivation to Combine, Obviousness, Patent, Patent Cases 2006, Pharma, Public Use, Teaching Awayanticipation, Enablement, obviousness, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
In Preliminary Injunction Decision, CAFC Forecasts Post-eBay Jurisprudence December 11, 2006CAFC, Chemical, Injunctions, Patent, Patent Cases 2006, Pharmaanticipation, obviousness, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.